US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
CN1325301A
(zh)
*
|
1998-11-02 |
2001-12-05 |
阿尔扎有限公司 |
活性物质的控制释放
|
JP2002534139A
(ja)
*
|
1999-01-05 |
2002-10-15 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
網膜と脈絡膜への経強膜徐放性薬剤標的送達
|
ES2239065T3
(es)
|
1999-12-16 |
2005-09-16 |
Alza Corporation |
Formas de dosificacion que presentan una capa barrera frente a la ablacion con laser.
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
US6616876B1
(en)
*
|
2000-10-03 |
2003-09-09 |
Atrium Medical Corporation |
Method for treating expandable polymer materials
|
US6923927B2
(en)
*
|
2000-10-03 |
2005-08-02 |
Atrium Medical Corporation |
Method for forming expandable polymers having drugs or agents included therewith
|
US7396542B2
(en)
*
|
2001-12-28 |
2008-07-08 |
Teva Pharmaceutical Industries Ltd. |
Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
WO2004000284A1
(en)
|
2002-06-21 |
2003-12-31 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US6559293B1
(en)
*
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
IL163846A0
(en)
|
2002-03-01 |
2005-12-18 |
Univ South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
ATE401860T1
(de)
*
|
2002-03-29 |
2008-08-15 |
Alza Corp |
Volumensparende arzneiform zur kontrollierten freisetzung
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
AU2003269744A1
(en)
*
|
2002-05-15 |
2003-12-02 |
Sun Pharmaceutical Industries Limited |
Oral osmotic controlled drug delivery system
|
EP1515701B1
(en)
|
2002-06-17 |
2014-09-17 |
Inventia Healthcare Private Limited |
Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20050208132A1
(en)
*
|
2002-07-29 |
2005-09-22 |
Gayatri Sathyan |
Methods and dosage forms for reducing side effects of benzisozazole derivatives
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
EP1534238A1
(en)
*
|
2002-07-29 |
2005-06-01 |
ALZA Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
DE60326590D1
(de)
*
|
2002-07-29 |
2009-04-23 |
Glaxo Group Ltd |
Tend lamotrigin
|
AU2003267231A1
(en)
*
|
2002-09-20 |
2004-04-08 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
AU2003295846A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations of celcoxib
|
US7988993B2
(en)
*
|
2002-12-09 |
2011-08-02 |
Andrx Pharmaceuticals, Inc. |
Oral controlled release dosage form
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
US20040166160A1
(en)
*
|
2003-01-14 |
2004-08-26 |
Ramkumar Subramanian |
Methods and dosage forms with modified viscosity layers
|
US20060167435A1
(en)
*
|
2003-02-18 |
2006-07-27 |
Adamis Anthony P |
Transscleral drug delivery device and related methods
|
EP1608339B8
(en)
|
2003-02-28 |
2012-04-25 |
McNeill-PPC, Inc. |
Pharmaceutical co-crystal of celecoxib-nicotinamide
|
US7442387B2
(en)
*
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
US20040214893A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Matthew Peterson |
Gabapentin compositions
|
US7186863B2
(en)
|
2003-05-23 |
2007-03-06 |
Transform Pharmaceuticals, Inc. |
Sertraline compositions
|
WO2005016306A2
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
CA2540308C
(en)
|
2003-09-26 |
2013-08-06 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
WO2005030182A1
(en)
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
KR20060115860A
(ko)
*
|
2003-09-26 |
2006-11-10 |
알자 코포레이션 |
활성 제제의 서방성 전달을 위한 oros 푸시-스틱
|
WO2005030181A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
KR20060130571A
(ko)
*
|
2003-10-31 |
2006-12-19 |
알자 코포레이션 |
개선된 흡수를 위한 조성물 및 제형
|
US20050113410A1
(en)
*
|
2003-11-03 |
2005-05-26 |
Mark Tawa |
Pharmaceutical salts of zafirlukast
|
WO2005051298A2
(en)
|
2003-11-19 |
2005-06-09 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
EP2292213A1
(en)
|
2004-02-06 |
2011-03-09 |
Cephalon, Inc. |
Compositions comprising a polymorphic form of armodafinil
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20060004037A1
(en)
*
|
2004-03-25 |
2006-01-05 |
Transform Pharmaceuticals, Inc. |
Novel tricyclic compounds and related methods of treatment
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
US7803786B2
(en)
*
|
2004-06-17 |
2010-09-28 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions and related methods of use
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US8779175B2
(en)
|
2004-10-25 |
2014-07-15 |
Synthonics, Inc. |
Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
|
WO2006073779A1
(en)
*
|
2004-12-30 |
2006-07-13 |
Transform Phamaceuticals, Inc. |
Novel omeprazole forms and related methods
|
US20060165798A1
(en)
*
|
2005-01-27 |
2006-07-27 |
Edgren David E |
Oral osmotic dosage form having a high flux membrane
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006101584A2
(en)
*
|
2005-03-15 |
2006-09-28 |
Diversa Corporation |
Cellulases, nucleic acids encoding them and methods for making and using them
|
EP2474308A1
(en)
*
|
2005-06-27 |
2012-07-11 |
Valeant International (Barbados) SRL |
Pharmaceutical formulations containing bupropion hydrobromide
|
RU2433821C2
(ru)
*
|
2005-08-30 |
2011-11-20 |
Пирамал Лайф Сайнсис Лимитед |
Фармацевтическая композиция метформина с длительным высвобождением и способ ее получения
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20080070990A1
(en)
*
|
2006-05-30 |
2008-03-20 |
Stirling Products Limited |
Use of ractopamine enantiomers
|
CA2651855C
(en)
|
2006-05-30 |
2011-08-02 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
US20070282010A1
(en)
|
2006-05-30 |
2007-12-06 |
Bridge Pharma, Inc. |
Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals
|
US8703191B2
(en)
*
|
2006-07-25 |
2014-04-22 |
Intelgenx Corp. |
Controlled-release pharmaceutical tablets
|
US7674479B2
(en)
*
|
2006-07-25 |
2010-03-09 |
Intelgenx Corp. |
Sustained-release bupropion and bupropion/mecamylamine tablets
|
KR101200728B1
(ko)
|
2006-08-09 |
2012-11-13 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 전달 시스템 및 피스톤 조립체
|
US9114133B2
(en)
|
2006-08-25 |
2015-08-25 |
U.S. Dept. Of Veterans Affairs |
Method of improving diastolic dysfunction
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
US20080176955A1
(en)
*
|
2007-01-16 |
2008-07-24 |
Victory Pharma, Inc. |
Combined administration of benzonatate and guaifenesin
|
EP2786985B1
(en)
|
2007-02-09 |
2018-11-28 |
Metabasis Therapeutics, Inc. |
Antagonists of the glucagon receptor
|
CA2678806C
(en)
*
|
2007-02-21 |
2017-05-16 |
Connected Health Systems, Llc |
Treating adhd and other diseases involving inflammation
|
CA2683610C
(en)
|
2007-04-23 |
2013-01-08 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US8637080B2
(en)
|
2007-06-28 |
2014-01-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Rupturing controlled release device comprising a subcoat
|
JP5572549B2
(ja)
|
2007-08-13 |
2014-08-13 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
グルコキナーゼの新規な活性化剤
|
AU2008331928B2
(en)
*
|
2007-12-03 |
2012-08-16 |
Bridge Pharma, Inc. |
Use of RR/SR-ractopamine
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
BRPI0911874A2
(pt)
*
|
2008-04-29 |
2018-05-22 |
Pharnext |
composições combinadas para o tratamento da doença de alzheimer e doenças relacionadas com zonisamida e acamprosato
|
CN102316730A
(zh)
*
|
2008-05-09 |
2012-01-11 |
天雅瑞药业有限公司 |
用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
|
PL2799428T3
(pl)
|
2008-08-13 |
2017-05-31 |
Metabasis Therapeutics, Inc. |
Antagoniści glukagonu
|
CN101703488B
(zh)
*
|
2008-12-16 |
2013-02-20 |
北京科信必成医药科技发展有限公司 |
具有润滑层结构的双层渗透泵控释片及其制备方法
|
EP2462246B1
(en)
|
2009-09-28 |
2017-09-06 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
US10610528B2
(en)
|
2009-12-08 |
2020-04-07 |
Intelgenx Corp. |
Solid oral film dosage forms and methods for making same
|
US20110136815A1
(en)
|
2009-12-08 |
2011-06-09 |
Horst Zerbe |
Solid oral film dosage forms and methods for making same
|
AU2011237592B2
(en)
|
2010-04-08 |
2016-10-27 |
Emory University |
Substituted androst-4-ene diones
|
US9000046B2
(en)
|
2010-09-28 |
2015-04-07 |
Depomed, Inc. |
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9585930B2
(en)
|
2011-03-20 |
2017-03-07 |
Trustees Of Boston University |
Therapeutic agent for emphysema and COPD
|
WO2013003697A1
(en)
|
2011-06-30 |
2013-01-03 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
US9102105B2
(en)
*
|
2011-09-13 |
2015-08-11 |
Vista Scientific Llc |
Method for forming an ocular drug delivery device
|
EP3036226B1
(en)
|
2013-08-22 |
2020-01-08 |
The General Hospital Corporation |
Inhibitors of human 12/15-lipoxygenase
|
US10076504B2
(en)
|
2014-06-12 |
2018-09-18 |
Ligand Pharmaceuticals, Inc. |
Glucagon antagonists
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
US11593764B2
(en)
*
|
2015-12-28 |
2023-02-28 |
Data Vault Holdings, Inc. |
Remote medication delivery systems
|
US11437139B2
(en)
|
2015-12-28 |
2022-09-06 |
Data Vault Holdings, Inc. |
Method and apparatus for biometric data collection combining visual data with historical health records metadata
|
AU2017268161B2
(en)
|
2016-05-16 |
2020-03-12 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
WO2018129058A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
CA3130379A1
(en)
*
|
2019-03-05 |
2020-09-10 |
Kashiv Biosciences, Llc |
Delayed release methylphenidate compositions
|
RU2754850C1
(ru)
*
|
2020-07-20 |
2021-09-08 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" |
Способ определения скорости высвобождения инкапсулированного в ниосомы цефотаксима in vitro
|